WallStreetZenWallStreetZen

NYSE: IQV
Iqvia Holdings Inc Stock Forecast, Predictions & Price Target

Open Broker Account
OverviewForecast
EarningsDividendOwnership

Analyst price target for IQV

Based on 14 analysts offering 12 month price targets for Iqvia Holdings Inc.
Min Forecast
$231.00+9.79%
Avg Forecast
$249.07+18.37%
Max Forecast
$290.00+37.83%

Should I buy or sell IQV stock?

Based on 14 analysts offering ratings for Iqvia Holdings Inc.
Strong Buy
Strong Buy
8 analysts 57.14%
Buy
3 analysts 21.43%
Hold
3 analysts 21.43%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IQV stock forecasts and price targets.

IQV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Cowen & Co.
Bottom 6%
6
BuyInitiates Coverage On$251.00+19.29%2022-12-06
Citigroup
Top 5%
96
HoldDowngrades$245.00+16.44%2022-11-17
Mizuho
Top 11%
90
Strong BuyMaintains$250.00+18.82%2022-11-10
Credit Suisse
Top 7%
94
BuyMaintains$265.00+25.94%2022-10-27
Morgan Stanley
Bottom 4%
4
Strong BuyMaintains$240.00+14.06%2022-10-27
Barclays
Bottom 3%
3
Strong BuyMaintains$235.00+11.69%2022-10-27
Guggenheim
Top 8%
93
Strong BuyMaintains$234.00+11.21%2022-10-10
SVB Leerink
Bottom 25%
25
BuyInitiates Coverage On$256.00+21.67%2022-07-15
Piper Sandler
Bottom 4%
4
Strong BuyUpgrades$255.00+21.19%2022-04-29
KeyBanc
Top 16%
85
Strong BuyMaintains$250.00+18.82%2022-04-28

1 of 2

Forecast return on equity

Is IQV forecast to generate an efficient return?
Company
49.4%
Industry
63.08%
Market
62.68%
IQV's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IQV forecast to generate an efficient return on assets?
Company
10.9%
Industry
14.72%
IQV is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IQV earnings per share forecast

What is IQV's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$9.37+49.68%
Avg 2 year Forecast
$10.55+68.53%
Avg 3 year Forecast
$12.14+93.93%
IQV's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

IQV revenue forecast

What is IQV's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$14.5B+1.27%
Avg 2 year Forecast
$15.9B+11.32%
Avg 3 year Forecast
$17.6B+23.06%
IQV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IQV earnings growth forecast

How is IQV forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
24.34%
Industry
19.31%
Market
17.05%
IQV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
IQV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
IQV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

IQV revenue growth forecast

How is IQV forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
7.07%
Industry
7.64%
Market
6.67%
IQV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IQV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IQV vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
IQV$210.41$249.07+18.37%Strong Buy
IDXX$428.54$473.13+10.40%Strong Buy
ILMN$210.42$260.18+23.65%Buy
MTD$1,482.73$1,377.60-7.09%Buy
A$156.28$152.67-2.31%Buy
View Top Diagnostic & Research Stocks

Iqvia Holdings Stock Forecast FAQ

Is Iqvia Holdings Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NYSE: IQV) stock is to Strong Buy IQV stock.

Out of 14 analysts, 8 (57.14%) are recommending IQV as a Strong Buy, 3 (21.43%) are recommending IQV as a Buy, 3 (21.43%) are recommending IQV as a Hold, 0 (0%) are recommending IQV as a Sell, and 0 (0%) are recommending IQV as a Strong Sell.

If you're new to stock investing, here's how to buy Iqvia Holdings stock.

What is IQV's earnings growth forecast for 2022-2024?

(NYSE: IQV) Iqvia Holdings's forecast annual earnings growth rate of 24.34% is forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 19.31%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 17.05%.

Iqvia Holdings's earnings in 2022 is $1,182,000,000.On average, 7 Wall Street analysts forecast IQV's earnings for 2022 to be $1,740,384,016, with the lowest IQV earnings forecast at $1,684,662,009, and the highest IQV earnings forecast at $1,764,530,219. On average, 7 Wall Street analysts forecast IQV's earnings for 2023 to be $1,959,557,243, with the lowest IQV earnings forecast at $1,855,542,830, and the highest IQV earnings forecast at $2,013,421,849.

In 2024, IQV is forecast to generate $2,254,883,879 in earnings, with the lowest earnings forecast at $2,097,004,860 and the highest earnings forecast at $2,375,614,894.

What is IQV's revenue growth forecast for 2022-2024?

(NYSE: IQV) Iqvia Holdings's forecast annual revenue growth rate of 7.07% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.64%, and while it is forecast to beat the US market's average forecast revenue growth rate of 6.67%.

Iqvia Holdings's revenue in 2022 is $14,307,000,000.On average, 7 Wall Street analysts forecast IQV's revenue for 2022 to be $2,691,123,484,419, with the lowest IQV revenue forecast at $2,686,480,541,064, and the highest IQV revenue forecast at $2,695,412,778,770. On average, 7 Wall Street analysts forecast IQV's revenue for 2023 to be $2,958,181,418,189, with the lowest IQV revenue forecast at $2,893,289,054,873, and the highest IQV revenue forecast at $3,017,532,413,658.

In 2024, IQV is forecast to generate $3,270,177,478,863 in revenue, with the lowest revenue forecast at $3,198,773,813,301 and the highest revenue forecast at $3,348,335,394,621.

What is IQV's forecast return on assets (ROA) for 2022-2025?

(NYSE: IQV) forecast ROA is 10.9%, which is lower than the forecast US Diagnostics & Research industry average of 14.72%.

What is IQV's Price Target?

According to 14 Wall Street analysts that have issued a 1 year IQV price target, the average IQV price target is $249.07, with the highest IQV stock price forecast at $290.00 and the lowest IQV stock price forecast at $231.00.

On average, Wall Street analysts predict that Iqvia Holdings's share price could reach $249.07 by Dec 6, 2023. The average Iqvia Holdings stock price prediction forecasts a potential upside of 18.37% from the current IQV share price of $210.41.

What is IQV's Earnings Per Share (EPS) forecast for 2022-2024?

(NYSE: IQV) Iqvia Holdings's current Earnings Per Share (EPS) is $6.26. On average, analysts forecast that IQV's EPS will be $9.37 for 2022, with the lowest EPS forecast at $9.07, and the highest EPS forecast at $9.50. On average, analysts forecast that IQV's EPS will be $10.55 for 2023, with the lowest EPS forecast at $9.99, and the highest EPS forecast at $10.84. In 2024, IQV's EPS is forecast to hit $12.14 (min: $11.29, max: $12.79).

What is IQV's forecast return on equity (ROE) for 2022-2025?

(NYSE: IQV) forecast ROE is 49.4%, which is considered strong.
©2022 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.